Disclosed is a method for the purification of biologically active Vaccinia virus comprising: i) loading a solid-phase matrix, to which a ligand is attached, with a Vaccinia virus contained in a liquid-phase culture, wherein the ligand is glucosamine glycan (GAG) or a GAG-like ligand ii) washing the matrix and iii) eluting the virus.